Skip to content
November 3, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Breast Cancer Legislation and Policy
  • Navigating the Shift: A Comprehensive Analysis of Section 1115 Medicaid Waivers
  • Breast Cancer Legislation and Policy

Navigating the Shift: A Comprehensive Analysis of Section 1115 Medicaid Waivers

Raul Delapena Setiawan November 3, 2026 7 minutes read
navigating-the-shift-a-comprehensive-analysis-of-section-1115-medicaid-waivers

Executive Summary: The Evolving Landscape of Medicaid Flexibility

Section 1115 of the Social Security Act grants the Secretary of Health and Human Services (HHS) the authority to approve "demonstration projects" that allow states to test innovative approaches to the Medicaid program. These waivers permit states to deviate from federal statutory requirements, provided the Secretary determines the proposal is likely to "promote the objectives" of Medicaid.

As of late 2026, the landscape of these waivers is undergoing a significant transformation. The transition from the Biden-Harris administration to the second Trump administration has marked a pivot point in federal priorities. While the previous administration utilized 1115 authority to emphasize social determinants of health (SDOH), justice-involved reentry, and extended continuous eligibility for children, the current administration has moved to rescind key guidance, tighten oversight, and prioritize traditional program structures, including mandatory work requirements.

Medicaid Waiver Tracker: Approved and Pending Section 1115 Waivers by State

The Mechanics of Flexibility

At its core, a Section 1115 waiver is a tool for state-level policy experimentation. States use this authority to modify eligibility, expand benefits, or restructure service delivery systems. Because Medicaid is a joint federal-state program, these waivers function as a negotiation between state houses and the federal government.

Nearly every state in the union currently operates at least one active Section 1115 waiver, illustrating the program’s reliance on state-specific tailoring. However, the "objectives" of these waivers—whether they prioritize broad access to care or fiscal austerity and administrative efficiency—often reflect the prevailing political ideology of the White House.

Medicaid Waiver Tracker: Approved and Pending Section 1115 Waivers by State

Chronology of Regulatory Shifts (2023–2026)

The trajectory of 1115 policy over the past three years highlights a rapid cycle of administrative rulemaking and subsequent reversal:

  • 2023: The Biden administration issues a comprehensive framework for Health-Related Social Needs (HRSN), allowing states to use federal Medicaid funds for services like nutrition support and housing assistance. Simultaneously, new guidance encourages states to adopt "pre-release" coverage for incarcerated individuals to facilitate smoother transitions to community-based care.
  • January 2024: Mandatory 12-month continuous eligibility for children takes effect nationwide via the Consolidated Appropriations Act, building on existing waiver momentum.
  • March 2025: The Trump administration formally rescinds the HRSN guidance. While existing waivers remain intact, the federal government pivots to a "case-by-case" review process, signaling a more restrictive approval environment.
  • April 2025: The administration moves to phase out "Designated State Health Programs" (DSHP) funding, a common tool states used to finance waiver-related infrastructure.
  • July 2025: A critical inflection point occurs when the administration releases guidance confirming it will no longer approve or extend multi-year continuous eligibility for children or adults. Additionally, initiatives aimed at bolstering the Medicaid workforce for primary care and behavioral health are slated for sunsetting.
  • January 2027: The effective date for the federal mandate requiring states to implement work requirements for ACA expansion adults.

Key Policy Themes: From Expansion to Restriction

1. Work Requirements: The Return of a Central Pillar

The implementation of work requirements represents one of the most contentious areas of Medicaid policy. Following the 2025 federal budget law, states are now required to condition eligibility on work status. While some states are opting to implement these via State Plan Amendments (SPAs) to beat the January 2027 deadline, others are navigating the waning utility of 1115 waivers for this purpose.

Medicaid Waiver Tracker: Approved and Pending Section 1115 Waivers by State

Georgia remains a notable outlier as the only state with an active work requirement waiver that survived extensive litigation. However, even Georgia must pivot to align with the new federal standard by the start of 2027. Nebraska, Montana, and Iowa are among the states preparing for early enforcement through SPAs, setting the stage for a national shift in how Medicaid enrollment is maintained.

2. Social Determinants of Health (SDOH)

Under the previous administration, the HRSN framework was a cornerstone of federal policy. By addressing housing and nutrition as "health-related," the program sought to reduce long-term medical costs. Today, while current approvals stand, the policy environment is significantly cooler. The shift to a "case-by-case" review suggests that new, expansive SDOH waivers face an uphill battle for federal approval. States must now demonstrate that such investments yield immediate, measurable clinical outcomes rather than broader systemic benefits.

Medicaid Waiver Tracker: Approved and Pending Section 1115 Waivers by State

3. Justice-Involved Reentry

The "pre-release" coverage model is one of the few areas of bipartisan agreement. Both Democratic and Republican governors have pursued these waivers to ensure that individuals leaving incarceration have immediate access to health coverage, which is statistically linked to lower recidivism and better health outcomes. Despite the change in administration, the Trump team approved five additional reentry waivers in late 2026, suggesting that this specific type of demonstration may continue to find favor even as other expansionary policies are curtailed.

Supporting Data: The Current State of Play

Analysis of current Medicaid.gov filings indicates a stark contrast between the breadth of active waivers and the narrowing scope of pending applications.

Medicaid Waiver Tracker: Approved and Pending Section 1115 Waivers by State
  • Eligibility Expansions: Historically, waivers were used to expand coverage to specific vulnerable populations, such as those with behavioral health needs or children with complex disabilities. The current pipeline of pending waivers is significantly thinner in these areas compared to 2024, as states wait to see how the administration’s new, more restrictive criteria will be applied to future applications.
  • Benefit Restrictions: There is a growing trend toward "healthy behavior" incentives and stricter copayment structures. Several states are actively proposing to remove previously approved incentives, signaling a move toward more traditional, fee-for-service-oriented benefit structures.

Official Responses and Administrative Stance

The federal government’s posture is characterized by a "return to basics." The administration’s official guidance emphasizes that Medicaid is a safety-net program intended for low-income individuals who meet strict eligibility criteria, and that the "waiver" process should not be used as a backdoor for permanent, large-scale expansions of the program.

State Medicaid directors find themselves in a precarious position. Those who invested heavily in infrastructure for HRSN or multi-year continuous eligibility now face the reality that these programs may not be renewed. The transition period between 2026 and 2028—when premium prohibitions for ACA expansion adults also kick in—is creating a complex regulatory environment where states must balance new federal mandates with the sunsetting of their own, previously approved innovations.

Medicaid Waiver Tracker: Approved and Pending Section 1115 Waivers by State

Implications for the Future of Medicaid

The "Churn" Factor

The move to end multi-year continuous eligibility and strictly enforce work requirements is expected to increase "churn"—the phenomenon where beneficiaries cycle on and off the program due to administrative requirements. Public health advocates warn that this will lead to fragmented care and, ultimately, higher costs for emergency departments as preventative care is disrupted.

Legal and Fiscal Uncertainty

The legal landscape remains volatile. As seen in the case of the "Healthy Indiana Plan 2.0," federal courts are increasingly willing to vacate waivers that they believe exceed the Secretary’s authority or conflict with the underlying intent of the Medicaid statute. The appeal by Indiana regarding premiums and non-emergency medical transportation (NEMT) suggests that litigation will remain a primary tool for both states and advocacy groups to shape the future of these programs.

Medicaid Waiver Tracker: Approved and Pending Section 1115 Waivers by State

A Narrower Window for Innovation

The era of broad, administration-led "demonstration" opportunities appears to be drawing to a close. Future 1115 waivers are likely to be limited to targeted, small-scale pilot programs rather than the systemic transformations that defined the 2022–2024 period. For states, this means that the "flexibility" promised by Section 1115 is becoming increasingly constrained by federal mandates and a more rigorous, skeptical review process.

Conclusion

The Section 1115 waiver program remains a vital, albeit increasingly restricted, component of the American healthcare landscape. As the U.S. moves toward the 2027 implementation of federal work requirements, the focus of state Medicaid programs will necessarily shift from expansion and social-need integration to administrative compliance and the maintenance of core, traditional services. While the "reentry" and "justice-involved" initiatives provide a rare area of continued growth, the overarching trend is one of retrenchment. Policymakers, healthcare providers, and beneficiaries must prepare for a period of adjustment as these federal changes ripple through the state-level systems that provide coverage to millions of Americans.

About the Author

Raul Delapena Setiawan

Author

View All Posts

Post navigation

Previous: From Patient to Practitioner: How One Mother’s Cancer Journey Inspired a Life of Service

Related Stories

the-invisible-crisis-chronic-illness-and-the-fractured-future-of-american-health-policy
  • Breast Cancer Legislation and Policy

The Invisible Crisis: Chronic Illness and the Fractured Future of American Health Policy

Basiran November 2, 2026
medicare-part-d-warning-2027-premium-hikes-demand-immediate-action-from-millions-of-seniors
  • Breast Cancer Legislation and Policy

Medicare Part D Warning: 2027 Premium Hikes Demand Immediate Action from Millions of Seniors

Lina Hope November 2, 2026
navigating-the-2027-aca-marketplace-a-landscape-of-rising-costs-and-regulatory-flux
  • Breast Cancer Legislation and Policy

Navigating the 2027 ACA Marketplace: A Landscape of Rising Costs and Regulatory Flux

Siti Muinah November 1, 2026

Recent Posts

  • Navigating the Shift: A Comprehensive Analysis of Section 1115 Medicaid Waivers
  • From Patient to Practitioner: How One Mother’s Cancer Journey Inspired a Life of Service
  • The Price of Uncertainty: Why Breast Reconstruction Costs Remain Hidden Despite Federal Transparency Mandates
  • Market Divergence: AstraZeneca, Alnylam, and Regeneron Navigate a Volatile Q3 Earnings Season
  • The Global Seesaw: Can Trump’s "Most Favored Nation" Gamble Spur Medical Innovation?

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

navigating-the-shift-a-comprehensive-analysis-of-section-1115-medicaid-waivers
  • Breast Cancer Legislation and Policy

Navigating the Shift: A Comprehensive Analysis of Section 1115 Medicaid Waivers

Raul Delapena Setiawan November 3, 2026
from-patient-to-practitioner-how-one-mothers-cancer-journey-inspired-a-life-of-service
  • Survivorship and Post-Treatment

From Patient to Practitioner: How One Mother’s Cancer Journey Inspired a Life of Service

Siti Muinah November 3, 2026
the-price-of-uncertainty-why-breast-reconstruction-costs-remain-hidden-despite-federal-transparency-mandates
  • Breast Cancer Surgery and Reconstruction

The Price of Uncertainty: Why Breast Reconstruction Costs Remain Hidden Despite Federal Transparency Mandates

Basiran November 3, 2026
market-divergence-astrazeneca-alnylam-and-regeneron-navigate-a-volatile-q3-earnings-season
  • Chemotherapy and Targeted Therapy

Market Divergence: AstraZeneca, Alnylam, and Regeneron Navigate a Volatile Q3 Earnings Season

Nana Wu November 3, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.